Related Experiment Video
Updated: Oct 2, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients
Susanne Mohr1, Xia Xi, Jie Tang
1Department of Medicine, Case Western Reserve University, Center for Diabetes Research, Cleveland, Ohio 44106, USA. sxm38@po.cwru.edu
Abstract:
Apoptosis of retinal capillary cells begins early in diabetes and likely contributes to the capillary obliteration that is an important feature of diabetic retinopathy. Caspases are proteolytic enzymes that are closely involved in the induction and execution phases of apoptosis, but their role in the development of diabetic retinopathy has not been studied previously. Our study focused on the measurement of activities of multiple caspases in retinas of mice at different durations of diabetes. Several caspases (including caspases-1, -2, -6, -8, and -9) were activated as early as 2 months of diabetes. The caspases activity pattern changed with increasing duration of disease, suggesting a slowly developing caspases cascade. Activities of executioner caspases (e.g., cas-6 and -3) became elevated after longer duration of diabetes, and the induction of cas-3 activity was associated with the duration of diabetes at which capillary cells begin to show evidence of undergoing apoptosis. Retinas from patients with type 2 diabetes likewise showed a significant increase in activities of cas-1, -3, -4, and -6. For comparison, retinal caspases were also measured in experimental galactosemia, another model that develops a diabetic-like retinopathy. The pattern of caspases activation differed between diabetes and galactosemia, but cas-1 activity became elevated soon after elevation of blood hexose concentration in both. Caspases offer new therapeutic targets to test the role of apoptosis in the development of diabetic retinopathy.
Insights
Early activation of caspases, key enzymes in apoptosis, occurs in diabetic retinopathy. This finding suggests caspases are potential therapeutic targets for managing this vision-threatening complication.
Area of Science:
- Ophthalmology
- Molecular Biology
- Endocrinology
Background:
- Diabetic retinopathy involves apoptosis of retinal capillary cells.
- Caspases are crucial enzymes in apoptosis but their role in diabetic retinopathy is unstudied.
Purpose of the Study:
- To measure caspase activities in mouse retinas during diabetes progression.
- To investigate the role of caspases in diabetic retinopathy development.
Main Methods:
- Assessed activities of multiple caspases (caspase-1, -2, -3, -4, -6, -8, -9) in mouse retinas at various diabetes durations.
- Analyzed caspase activities in human type 2 diabetic retinas and experimental galactosemia models.
Main Results:
- Several caspases were activated as early as 2 months in diabetic mouse retinas.
- Executioner caspases (caspase-6, -3) activities increased with longer diabetes duration.
- Elevated caspase activities (caspase-1, -3, -4, -6) were observed in human diabetic retinas.
Conclusions:
- Caspase activation is an early event in diabetic retinopathy.
- Caspase cascades play a significant role in the development of diabetic retinopathy.
- Caspases represent promising therapeutic targets for diabetic retinopathy.

